BIS icon

ProShares UltraShort NASDAQ Biotechnology
BIS

Overview Fund Trends Analyst Outlook Journalist POV

7 hedge funds and large institutions have $4.82M invested in ProShares UltraShort NASDAQ Biotechnology in 2014 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding: →

less call options, than puts

Call options by funds: $ | Put options by funds: $
Holders
7
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$1.38M
Puts
$2.79M
Net Calls
Net Calls Change

Top Buyers

1
+$2.23M
2
+$891K
3
+$891K
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$471K
5
SM
Southport Management
Wyoming
+$267K

Top Sellers

1
-$43K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$2.23M
2
$891K
3
$891K
4
$471K
5
$267K
6
$36K
7
$32K
8
–